Angiotensin II (AII) induced the proliferation of hematopoietic progenitor
cells (HPC) isolated from murine bone marrow or human cord blood. The forma
tion of colonies with more than 50 cells increased approximately five-seven
fold in cultures of murine lineage-negative (Lin(-)) bone marrow cells both
in the presence (day 10) and absence (day 13) of colony-stimulating factor
s (CSF), This could be blocked with addition of Losartan, an antagonist of
AIITR1. The increase in proliferation of early hematopoietic progenitors (L
in(-)Sca I+ cells) by AII was approximately threefold and occurred only in
the presence of CSF, suggesting that AII may affect mesenchymal stromal cel
ls to induce CSF production and might directly affect early WC. These in vi
tro studies were replicated with human HPC isolated from cord blood. AII al
so accelerated the proliferation and formation of colony-forming units (CFU
)-granulocyte/erythroid/macrophage/megakaryocyte and CFU-granulocyte/macrop
hage colonies by CD34(+)CD38(-) enriched progenitors but only in the presen
ce of CSF. Additional studies also indicated that AII can act to increase p
roliferation in suspension culture. Exposure of CD34(+) cells to AII in sus
pension culture, prior to placement in a semisolid medium with erythropoiet
in, increased the formation of colonies with more than 50 cells and erythro
id progenitors approximately five- and 20-fold, respectively. Further, mRNA
for the AT1a receptor was expressed by human bone marrow CD34(+)CD38(-) ce
lls, CD34+CD38- cells, and lymphocytes, but not mature myeloid cells. Simil
arly, mRNA for the AT1a receptor was expressed on human stromal cell clones
, offering further support to the hypothesis that AII arts partially throug
h the mesenchymal compartment of the bone marrow. These data suggest that A
II may be a factor which stimulates the proliferation of hematopoietic prog
enitors.